Trial of Upadacitinib or Abatacept in Rheumatoid Arthritis

N Engl J Med. 2021 Jan 7;384(1):83. doi: 10.1056/NEJMc2033206.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Abatacept / therapeutic use
  • Arthritis, Rheumatoid* / drug therapy
  • Heterocyclic Compounds, 3-Ring*
  • Humans

Substances

  • Heterocyclic Compounds, 3-Ring
  • upadacitinib
  • Abatacept